Giorgio Vittorio Scagliotti
Giorgio Vittorio Scagliotti
Email verificata su - Home page
TitoloCitata daAnno
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
GV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ...
Journal of clinical oncology 26 (21), 3543-3551, 2008
Gefitinib in combination with paclitaxel and carboplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 2
RS Herbst, G Giaccone, JH Schiller, RB Natale, V Miller, C Manegold, ...
Journal of Clinical Oncology 22 (5), 785-794, 2004
Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1
G Giaccone, RS Herbst, C Manegold, G Scagliotti, R Rosell, V Miller, ...
Journal of Clinical Oncology 22 (5), 777-784, 2004
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
J Valle, H Wasan, DH Palmer, D Cunningham, A Anthoney, A Maraveyas, ...
New England Journal of Medicine 362 (14), 1273-1281, 2010
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ...
Journal of clinical oncology 26 (21), 3552-3559, 2008
Phase III randomized trial comparing three platinum-based doublets in advanced non–small-cell lung cancer
GV Scagliotti, F De Marinis, M Rinaldi, L Crino, C Gridelli, S Ricci, ...
Journal of Clinical Oncology 20 (21), 4285-4291, 2002
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer …
DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria, J Prausova, ...
J Clin Oncol 29 (9), 1125-1132, 2011
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies
G Scagliotti, N Hanna, F Fossella, K Sugarman, J Blatter, P Peterson, ...
The oncologist 14 (3), 253-263, 2009
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer
GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ...
Journal of the National Cancer Institute 95 (19), 1453-1461, 2003
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
S Bovio, A Cataldi, G Reimondo, P Sperone, S Novello, A Berruti, ...
Journal of endocrinological investigation 29 (4), 298-302, 2006
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
P Ceppi, M Volante, S Saviozzi, I Rapa, S Novello, A Cambieri, ...
Cancer 107 (7), 1589-1596, 2006
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer
G Scagliotti, S Novello, J Von Pawel, M Reck, JR Pereira, M Thomas, ...
J Clin Oncol 28 (11), 1835-1842, 2010
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, I Rapa, KD Danenberg, PV Danenberg, ...
Annals of Oncology 17 (12), 1818-1825, 2006
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non–small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crino, GV Scagliotti, S Ricci, F De Marinis, M Rinaldi, C Gridelli, ...
Journal of Clinical Oncology 17 (11), 3522-3530, 1999
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
L Crino, G Scagliotti, M Marangolo, F Figoli, M Clerici, F De Marinis, ...
Journal of clinical oncology 15 (1), 297-303, 1997
Lung cancer: current therapies and new targeted treatments
FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran Jr, YL Wu, ...
The Lancet 389 (10066), 299-311, 2017
Multicenter, phase II trial of sunitinib in previously treated, advanced non–small-cell lung cancer
MA Socinski, S Novello, JR Brahmer, R Rosell, JM Sanchez, CP Belani, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20